SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,151.04 905.01
( 1.24%)

Global Indices

Nasdaq

52,356.08 -140.02
(-0.27%)

Dow Jones

7,741.04 -23.94
(-0.31%)

Hang Seng

64,627.45 673.26
(1.05%)

Nikkei 225

10,729.94 35.44
(0.33%)

Forex

USD-INR

95.08 -0.03
(-0.03%)

EUR-INR

106.01 -0.48
(-0.45%)

GBP-INR

126.67 -0.36
(-0.28%)

JPY-INR

0.60 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

394.8213477

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

36.54

95225.04

EPS(TTM)

Face Value()

Div & Yield %

45.29

0.24

Back

artemis electicals & projects ltd

SG Mart consolidated net profit rises 103.54% in the September 2026 quarter

Oct 28,2026

Net profit of SG Mart rose 103.54% to Rs 54.02 crore in the quarter ended September 2026 as against Rs 26.54 crore during the previous quarter ended September 2025. Sales declined 8.36% to Rs 1561.84 crore in the quarter ended September 2026 as against Rs 1704.25 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	1561.84	1704.25	-8
OPM %	4.61	1.64	-
PBDT	73.47	35.49	107
PBT	69.06	33.15	108
NP	54.02	26.54	104

74,151.04 905.01 ( 1.24%)

52,356.08 -140.02 (-0.27%)

7,741.04 -23.94 (-0.31%)

64,627.45 673.26 (1.05%)

10,729.94 35.44 (0.33%)

95.08 -0.03 (-0.03%)

106.01 -0.48 (-0.45%)

126.67 -0.36 (-0.28%)

0.60 0.00 (-0.36%)